Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page footer now displays 'Revision: v3.3.2' and the previous 'Revision: v3.2.0' label is removed.SummaryDifference0.1%

- Check26 days agoChange DetectedThe page removed the general government funding/operating status notice at the top. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedAdded the label 'Last Update Posted (Estimated)'. Removed the label 'Last Update Posted'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedMedlinePlus Genetics related topics: Multiple myeloma was added to the page's related topics section.SummaryDifference0.9%

- Check70 days agoChange Detected- Updated revision from v3.1.0 to v3.2.0, and added government operating-status notice and a new topic link (Multiple myeloma) for MedlinePlus Genetics. The prior revision notice was removed (v3.1.0 deleted) in favor of v3.2.0.SummaryDifference3%

- Check77 days agoChange DetectedUpdated the page to use a unified term Multiple myeloma with a new revision tag v3.1.0, replacing older related topics and the older revision v3.0.2.SummaryDifference0.5%

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.